RAPI GIANFRANCO, PH.D.; PIETRO COCCHI, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: We read with interest the report by Edwards and colleagues (Ann Intern Med 89:91-106, 1978) on severe candidal infections and new concepts in therapy. We agree with the authors that the suitable antifungal agents for disseminated candidiasis are very few. Moreover, the usefulness of the most reliable agent, amphotericin B sodium deoxycholate complex, is severely limited because of its well-known toxicity. The future of new antifungal drugs does not seem particularly promising, with the probable exception of the amphotericin B water-soluble derivative methyl ester hydrochloride, still under investigation (1). Thus it may be of some interest to
GIANFRANCO R, COCCHI P. Antifungal Agents. Ann Intern Med. 1979;90:130. doi: https://doi.org/10.7326/0003-4819-90-1-130_1
Download citation file:
Published: Ann Intern Med. 1979;90(1):130.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use